Dexcom G6 Professional Continuous Glucose Monitor + INSULIN HUMAN for diabetes mellitus, type 2

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Sep 2020: Trial registered, NCT04542148
  2. 10 Feb 2022: Trial started, NCT04542148

The trials

NCT04542148: Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes

State
Under way
Phase
Phase 2
People
120 planned
Started
10 Feb 2022
Primary completion
30 Nov 2025
Arms
Continuous Insulin Infusion
Results
None posted
  1. 9 Sep 2020: Trial registered
  2. 10 Feb 2022: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.